US Edition
Eye Disease Is Now an Official Side Effect of Wegovy and Ozempic
5 Articles
5 Articles
Here you can follow today's news as they happen.
Novo Nordisk has previously denied the connection, but has now updated the package insert with a rare side effect.
Danish drugmaker Novo Nordisk has been ordered to warn about a rare eye disease on the packaging of its weight-management drugs. The company had previously denied that the disease was linked to the use of the drugs. Non-arteritic anterior ischemic optic neuropathy is a rare eye disease. The European Medicines Agency has ordered Novo Nordisk to state on the package inserts of its Ozempic, Wegovy and Rybelsus drugs that it is a very rare side effe…
Danish drugmaker Novo Nordisk has been ordered to add a warning to the packaging of its popular weight-loss drugs Ozempic, Wegovo and Rybelsus about a rare complication called NAION, which can lead to severe vision loss or total blindness, but is very rare, the European Medicines Agency has said.
The dangerous eye disease NAION is now listed as a rare side effect on the package inserts of diet and diabetes medications.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
